"Typical" heart patients not represented in trials
Posted on: Monday, 10 April 2006, 11:26 CDT
By Martha Kerr
NEW YORK (Reuters Health) - Patients enrolled in randomized clinical trials of coronary interventions are younger and have better cardiac risk profiles than the average patient in clinical practice, European heart doctors report. As such, they say, treatment "can only be partially evidence-based."
Dr. Eric Boersma from Erasmus Medical Center in Rotterdam, The Netherlands, and colleagues looked at the characteristics of 4713 heart patients in the Euro Heart Survey compared with those of 8,647 patients in 14 randomized heart treatment trials.
The investigators found that 64 percent of patients in their survey would not have met the strict enrollment criteria of the randomized clinical trials.
Compared with clinical trial patients, patients seen in everyday clinical practice are typically older, have more co-morbid illnesses, more likely to have single vessel disease, and more often have blockage of the left main coronary artery, Boersma and colleagues report.
"In the case in which the patient that is being treated is not represented in clinical trials, then his/her treatment can only be partly 'evidence based'," Boersma noted in comments to Reuters Health.
"In my view, treatment should then be based on a) observational studies; b) expert opinion; c) personal experience with certain treatment."
Once randomized clinical trials of strictly selected patients have been completed, it is time to conduct studies of more typical patients, Boersma asserted.
SOURCE: European Heart Journal March 2006.
Source: REUTERS
Related Articles
- Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
- Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
- Biogen Idec Initiates Phase III Clinical Trial for ADENTRI(R) in Acute Decompensated Heart Failure Patients With Renal Insufficiency
- Cytokinetics Announces Positive Results From an Interim Analysis of an Ongoing Phase IIa Clinical Trial of CK-1827452 in Patients With Stable Heart Failure
- Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane As Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
- CoGenesys Initiates Phase 1-2 Clinical Trial of Cardeva in Patients With Heart Failure
- Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate Cancer
- Clinical Trial to Begin for Stem Cell Treatment in Heart Patients
- ZymoGenetics Drug Advances to Clinical Trial
- Biopure Completes Patient Enrollment in European Phase 2 Clinical Trial of Hemopure(R) in Coronary Angioplasty Patients
User Comments (0)

RSS Feeds